Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Retraction
IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Retraction]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 2,845 | Dovepress* | 2,758+ | 143 | 2,901 | |
| PubMed Central* | 87 | 34 | 121 | ||
| Totals | 2,845 | 177 | 3,022 | ||
| *Since 22 August 2022 | |||||
View citations on PubMed and Google Scholar